Who
Thomas Joeseph Carrico
Cro, Cco, Cpo
Company insider
Files Form 4 as: Cro, Cco, Cpo, Neuraxis.
In numbers
- Trades disclosed
- 18
- Buys
- 2
- Sells
- 0
- Bought
- $4,202
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Jan 2025
- Last trade
- 8 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Oct 2026filed 8 Oct 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Bought | $1,588328 at $4.84 | filing |
| 24 Aug 2026filed 26 Aug 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | —193,678 | filing |
| 24 Aug 2026filed 26 Aug 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code C | $2.1M306,236 at $6.94 | filing |
| 24 Aug 2026filed 26 Aug 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | —306,236 | filing |
| 24 Aug 2026filed 26 Aug 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code C | $2.1M306,236 at $6.94 | filing |
| 24 Aug 2026filed 26 Aug 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | —306,236 | filing |
| 24 Aug 2026filed 26 Aug 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code C | —306,236 | filing |
| 24 Aug 2026filed 26 Aug 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code C | —306,236 | filing |
| 24 Aug 2026filed 26 Aug 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Code A | —193,678 | filing |
| 13 Aug 2026filed 17 Aug 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $853K135,906 at $6.28 | filing |
| 13 Aug 2026filed 17 Aug 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $853K135,906 at $6.28 | filing |
| 1 Apr 2026filed 3 Apr 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Bought | $1,307667 at $1.96 | filing |
| 1 Apr 2026filed 3 Apr 2026 | NRXS NeuraxisMedical Devices | SEC FORM 4 Bought | $1,307667 at $1.96 | filing |
| 22 Jan 2026filed 26 Feb 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $220K47,569 at $4.63 | filing |
| 22 Jan 2026filed 26 Feb 2026 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $220K47,569 at $4.63 | filing |
| 4 Mar 2025filed 10 Sep 2025 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $22K10,000 at $2.18 | filing |
| 4 Mar 2025filed 10 Sep 2025 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $60K27,435 at $2.18 | filing |
| 3 Jan 2025filed 10 Sep 2025 | NRXS Neuraxisoption or derivative · Medical Devices | SEC FORM 4 Code A | $85K35,000 at $2.42 | filing |
News
Head to Head Contrast: Green Thumb Industries (OTCMKTS:GTBIF) vs. NeurAxis (NASDAQ:NRXS)NRXS · dailypolitical.com · 18 Oct 2026Reviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR)NRXS · tickerreport.com · 15 Oct 2026Critical Analysis: Solventum (NYSE:SOLV) vs. NeurAxis (NASDAQ:NRXS)NRXS · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Thomas Joeseph Carrico; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.